miCLIP-seq: Precision in m6A Epitranscriptomics

In the realm of RNA modification research, miCLIP-seq represents a significant advancement. This high-resolution technique enables the precise mapping of N6-methyladenosine (m⁶A) and its derivative, m⁶Am, at single-nucleotide resolution, providing unparalleled insights into the epitranscriptome.

Key Advantages:

Single-Nucleotide Precision: Accurately identifies m⁶A and m⁶Am modifications at the single-nucleotide level, facilitating detailed analysis of RNA modifications.
Comprehensive Coverage: Applicable to a wide range of RNA species, including mRNA and small non-coding RNAs such as snoRNAs and miRNAs, expanding the scope of epitranscriptomic studies.
Non-invasive Methodology: Employs UV crosslinking and immunoprecipitation without the need for chemical labeling, preserving the native state of RNA and allowing the use of low-input samples.

Get a Quote

Illustration of miCLIP-seq precision in detecting m⁶A and m⁶Am modifications. The image shows mRNA, snoRNA, and miRNA strands bound by m⁶A-specific antibodies. A magnified region highlights a single m⁶A site causing a C→T mutation during reverse transcription, indicating base-resolution detection. The right panel emphasizes 'Single-Nucleotide Precision' and 'm⁶A & m⁶Am Detection.

Introduction

Why Your m⁶A Study Deserves Better Than "Broad Peaks"?

If you've worked with MeRIP-seq, you're likely familiar with the frustration of broad "peaks" spanning 100–200 nucleotides, where it's unclear which exact adenosine is modified and drives gene expression. This lack of precision makes it challenging to connect m⁶A modifications to specific mechanistic functions within the RNA.

MeRIP-seq: A "Broad Peak" Isn't a Mechanistic Insight
MeRIP-seq provides large, imprecise peaks that can't identify the exact position of the m⁶A modification within the RNA. For mechanistic insights—whether the modification affects translation initiation or RNA stability—this broad approach is insufficient.
PAR-CLIP: Toxic Labels Compromise Sample Integrity
PAR-CLIP offers improved resolution but requires the use of toxic 4-SU, which alters RNA metabolism and makes it unsuitable for low-input or rare samples, such as primary cells. This limitation compromises the accuracy of the data in such samples.
Small RNA & m⁶Am: Overlooked Key Players in m⁶A Regulation
Existing methods also tend to overlook two critical aspects of m⁶A research:
- Small RNAs: Methods like MeRIP-seq often ignore small RNAs, such as snoRNAs and miRNA precursors, due to size selection filters (>200 nt).
- m⁶Am: The m6A-methylated adenosine at the 5' cap, which plays an essential role in mRNA stability, is often not distinguished from standard m⁶A modifications in other methods.

Comparative infographic of three RNA sequencing methods: MeRIP-seq (showing broad m⁶A peaks), PAR-CLIP (illustrated with chemical labels and a toxicity warning), and miCLIP-seq (featuring an m⁶A site and a magnified C→T mutation), emphasizing differences in resolution and sample integrity.

miCLIP-seq: The Precision You Need to Move Forward

miCLIP-seq addresses these gaps with a technique designed specifically for researchers requiring high precision:

Single-Nucleotide Resolution: No more ambiguity—miCLIP-seq maps m⁶A modifications at single-nucleotide resolution, ensuring that you know the exact location of each m⁶A modification on the RNA transcript.
Detects m⁶Am & Small RNAs: miCLIP-seq uniquely enables the detection of 5'-cap m⁶Am modifications and identifies m⁶A in small RNA species (such as snoRNAs and miRNA precursors), areas missed by other methods.
No Toxic Labels Required: Unlike PAR-CLIP, miCLIP-seq does not require the use of toxic nucleosides or live cell labeling, making it ideal for low-input RNA samples (as little as 5 µg of total RNA) and preserving sample integrity across a wide range of biological samples, including cell lines, tissues, and biofluids.

For high-resolution m⁶A research, miCLIP-seq is the only tool that provides the clarity and reliability needed for mechanistic studies and impactful research.

miCLIP-seq vs. Other Methods: Why It's the Gold Standard for Researchers

Feature	miCLIP-seq	MeRIP-seq	PAR-CLIP
Resolution	Single-nucleotide	100–200 nt	10–50 nt (but requires 4-SU)
m⁶Am Detection	✅ Yes	❌ No	❌ No
Small RNA Compatibility	✅ Yes (snoRNA, miRNA)	❌ No	✅ Yes (but 4-SU toxic)
Sample Integrity	No chemical labeling	No labeling	4-SU alters cell physiology
False Positive Rate	<1% (signature mutations)	15–30% (antibody cross-reactivity)	5–10% (4-SU bias)

Our Take: MeRIP-seq is great for discovery—but if you need to validate targets, study mechanism, or publish in top journals, miCLIP-seq is non-negotiable.

How miCLIP-seq Works: The Science Behind the Precision

miCLIP-seq is a highly precise technique for mapping m6A modifications. Here's how it works:

1. Antibody Binding + UV Cross-Linking: Locking in the Modification

We begin with your RNA sample—whether total, poly(A), or small RNA. The RNA is fragmented to 30–130 nt and incubated with a high-specificity anti-m6A antibody. After incubation, 254 nm UV light covalently cross-links the antibody to the m6A-modified adenosine. This step ensures that only the modified RNA is captured, eliminating false positives caused by non-specific antibody binding.

2. Signature Mutations: The "Fingerprint" of m6A

During reverse transcription, the antibody-m6A complex prevents the reverse transcriptase from proceeding, leading to C→T transitions or truncations at the exact m6A site. These mutations are unique to m6A and provide a precise "fingerprint" for each modification. This approach avoids the errors introduced by chemical labels like those used in PAR-CLIP.

3. High-Throughput Sequencing + Bioinformatics: Turning Mutations into Insights

The cDNA library is sequenced on an Illumina platform for depth and accuracy. Our custom bioinformatics pipeline ensures the following:

Single-Nucleotide Precision: m6A sites are called only when mutations are consistently observed across replicates, ensuring accuracy with <0.5% error rate.
Distinguishing m6Am: We differentiate m6A from m6Am using position and mutation patterns, ensuring clarity on 5' cap modifications.
Small RNA Analysis: miCLIP-seq annotates m6A in small RNAs like snoRNAs, miRNA precursors, and tRNAs, which are often overlooked by other methods.
Functional Insights: We integrate m6A data with RNA-seq and perform motif analysis to identify novel m6A motifs and correlate modification levels with gene expression.

The Result: A Base-Pair Resolution m6A Landscape

miCLIP-seq delivers a detailed, base-pair resolution map of m6A modifications across your transcriptome, providing the precision and context needed to understand how these modifications regulate RNA biology.

Applications

What miCLIP-seq Can Do for Your Research

miCLIP-seq captures m⁶A and m⁶Am modifications with single-nucleotide resolution, enabling precise, mechanistic insights across diverse RNA species. Whether you're studying protein-coding genes or small non-coding RNAs, miCLIP-seq delivers clarity where it matters most.

1. Dissect Functional m⁶A Sites in Cancer-Related Transcripts

Precisely map methylated adenosines in oncogenes such as MYC or EGFR, especially in 5′ UTR and 3′ UTR regions.
Identify specific sites that influence mRNA stability or translation—no ambiguity, just actionable targets.
Validate function through site-directed mutagenesis or RNA-binding protein assays.

2. Uncover m⁶A Dynamics in Stem Cell-Associated Small RNAs

Detect m⁶A in pri-miRNAs and snoRNAs, regions often missed in standard workflows.
Reveal how methylation impacts miRNA processing (e.g., pri-miR-126) or stem cell fate decisions.
Enable targeted studies of demethylases (e.g., FTO) and their regulatory effects.

3. Characterize m⁶A in Non-Coding RNAs

Profile m⁶A in short non-coding RNAs like snoRNA U3, involved in critical cellular functions such as rRNA modification.
Study how site-specific methylation affects RNA stability and interaction with proteins.
Explore previously uncharted methylation landscapes across the non-coding transcriptome.

miCLIP-seq provides resolution, confidence, and context—helping you move from descriptive lists to functional understanding. Whether you aim to map regulatory hotspots or uncover new layers of RNA biology, miCLIP-seq is built for discovery that goes deeper.

Service Workflow

Service Workflow: Tailored for Researchers

Our miCLIP-seq service is built around a streamlined, high-fidelity workflow designed for precision m⁶A mapping. Each step is optimized for consistency, sensitivity, and reproducibility—ensuring accurate detection of m⁶A and m⁶Am at single-nucleotide resolution.

Bioinformatics

Bioinformatics Analysis: From Raw Reads to Meaningful m⁶A Insights

High-resolution data alone is not enough. To truly understand m⁶A's role in RNA biology, you need analysis that goes beyond basic site calling. Our bioinformatics pipeline is built for interpretability and scientific depth—turning signature mutations into functional insight.

Key Features of Our Analysis Pipeline

Single-Nucleotide m⁶A & m⁶Am Annotation
We identify and annotate m⁶A sites with single-base resolution using mutation signatures (C→T transitions and truncations). m⁶Am modifications near the 5' cap are differentiated based on position and mutation context.
Small RNA Modification Mapping
Modifications in pri-miRNAs, snoRNAs, and other small RNAs are accurately detected—regions that are often excluded in conventional m⁶A studies.
Quantitative Peak Analysis
For each site, we calculate modification strength (mutation frequency and read depth), allowing comparative analysis between samples or conditions.
Transcript-Level Distribution
We provide positional mapping of m⁶A across gene regions (5' UTR, CDS, 3' UTR), enabling insight into potential regulatory roles.

Motif Enrichment Discovery
Beyond canonical RRACH motifs, we identify enriched sequence contexts specific to your dataset—highlighting novel regulatory patterns.
Integration with RNA-seq (Optional)
For clients providing matched RNA-seq data, we correlate m⁶A levels with gene expression changes, uncovering potential links between modification and transcript stability or translation.
Publication-Ready Outputs
Deliverables include annotated m⁶A sites (BED, GTF), motif logos, gene-level summaries, and visualizations for genome browser display (e.g., IGV tracks).

Sample Requirements

Sample Requirements: Ensuring Quality & Reproducibility

To ensure reliable and reproducible results, it is crucial that your samples meet our stringent quality standards. Below are the key sample requirements for miCLIP-seq, including RNA integrity, quantity, and other essential guidelines.

Parameter	Requirement	Notes
RNA Quality	RIN (RNA Integrity Number) > 7.5	RNA should be intact with minimal degradation (28S/18S rRNA ratio ≥ 1.8).
RNA Quantity	5–10 µg of total RNA, or 2–5 µg of poly(A) RNA / small RNA	Low input options available; please consult for protocols with lower RNA amounts.
Contaminants	RNA should be free from phenol, ethanol, and protein	Contaminants may interfere with RNA quality and affect downstream analysis.
Sample Type	Cell lines, fresh/frozen tissue, sorted cells, exosomal RNA	Suitable for a wide variety of sample types. No live-cell labeling required (unlike PAR-CLIP).
Storage & Shipping	Store RNA at -80°C	RNA should be shipped on dry ice to maintain integrity during transit.

Case

Case Study

miCLIP-seq in Neuronal Differentiation

Title: m⁶A methylation orchestrates IMP1 regulation of microtubules during human neuronal differentiation

Authors: Pierre Klein, Marija Petrić Howe, Jasmine Harley, et al.

Journal:Nature Communications

Publication Date: June 6, 2024

DOI: 10.1038/s41467-024-49139-7

In this study, the researchers employed miCLIP-seq to map m⁶A modifications in mRNAs during human neuronal differentiation. They identified specific m⁶A sites that regulate the expression of microtubule-associated proteins by the RNA-binding protein IMP1. These findings highlight the role of m⁶A in modulating RNA-protein interactions and influencing neuronal morphology.

Figure 4: IMP1 Recognizes and Binds Both m⁶A-Methylated and Non-Methylated RNA

FAQ

FAQ About miCLIP-seq

Q: What are the differences between miCLIP-seq and traditional MeRIP-seq?

A: miCLIP-seq (m6A individual-nucleotide-resolution cross-linking and immunoprecipitation) offers several advantages over traditional MeRIP-seq:

Single-Nucleotide Resolution: miCLIP-seq provides precise mapping of m6A modifications at the single-nucleotide level, whereas MeRIP-seq typically identifies broad peaks, making it challenging to pinpoint exact modification sites.
Detection of m6Am: miCLIP-seq can distinguish between m6A and m6Am (N6,2′-O-dimethyladenosine), a modification at the 5′ cap of mRNA, which is crucial for understanding mRNA stability and translation initiation.
Small RNA Analysis: miCLIP-seq enables the detection of m6A modifications in small RNAs, such as snoRNAs and miRNA precursors, which are often overlooked by MeRIP-seq due to size selection biases.
No Toxic Labels Required: Unlike some methods, miCLIP-seq does not require the use of toxic nucleoside analogs like 4-SU, preserving the integrity of the RNA and allowing the use of low-input or rare samples.

In summary, miCLIP-seq provides higher resolution and broader applicability, making it a more versatile tool for studying m6A modifications across various RNA species.

Q: I want to integrate my miCLIP-seq data with my ATAC-seq data—can you help with that?

A: Yes, we can. Our bioinformatics team has extensive experience in multi-omics integration. We can help correlate m⁶A profiles with chromatin accessibility (e.g., linking m⁶A sites to ATAC-seq peaks in gene promoters), gene expression (combining with RNA-seq to analyze m⁶A's impact on mRNA stability or translation), and non-coding RNAs (exploring m⁶A in regulatory RNAs like enhancer RNAs). Results will be presented as visualizations (heatmaps, scatter plots) to simplify mechanistic interpretation.

Q: What experiments do you recommend for validating the function of m⁶A sites?

A: We tailor recommendations to your research question. Common, reliable approaches include:

Mutation validation: Construct wild-type (WT) and m⁶A-site mutant (A→C) reporter vectors to test effects on mRNA stability or translation.
Reader protein binding: Use CLIP-seq or RIP-qPCR to verify interactions between m⁶A readers (e.g., YTHDF1) and your target site.
Functional phenotyping: Knock out/down methyltransferases (e.g., METTL3) or readers to assess changes in gene expression or cellular phenotypes (e.g., proliferation, differentiation). These methods help move from "site identification" to "mechanistic proof"—a key step for publishing in top journals.

Q: Can your data analysis distinguish between m⁶A and m⁶Am in your service? How?

A: Yes, we can. We use two robust features to separate these modifications:

Positional context: m⁶Am is almost exclusively found in the 5'-cap region of mRNAs, while m⁶A is primarily located in the 3' UTR, coding sequence (CDS), or other parts of the 5' UTR.
Mutation pattern: m⁶Am shows higher, more concentrated signature mutation (C→T) frequencies compared to m⁶A—due to the unique structure of the 5'-cap, which enhances antibody binding and reverse transcriptase stalling. Results will be clearly labeled as "m⁶A" or "m⁶Am" with genomic positions and mutation metrics, so you can easily explore their distinct functions (e.g., m⁶Am's role in mRNA cap stability vs. m⁶A's role in translation).